Published in Nat Rev Urol on May 07, 2013
Active surveillance for prostate cancer: current evidence and contemporary state of practice. Nat Rev Urol (2016) 1.21
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83
Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med (1996) 5.68
Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol (2012) 4.24
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA (1995) 2.14
Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol (1996) 1.77
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance. Urology (2013) 1.63
Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis (2012) 1.10
A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol (2013) 1.05
Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients. BJU Int (2012) 0.90
The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis. Arch Esp Urol (2011) 0.86